A cancer drug currently being tested in patients may have entered clinical trials based on an incorrect understanding of how ...

The Metastatic Colorectal Cancer Clinical Trials analysis report delivers important insights into ongoing research of 150+ pipeline Metastatic Colorectal Cancer Drugs, clinical strategies, upcoming ...

High-risk neuroblastoma is one of the most aggressive forms of solid tumors affecting children, originating in the nervous system. While a newer class of targeted immunotherapy drugs has improved ...

Chronic exposure to cigarette smoke may reprogram different populations of lung stem cells, which maintain and repair lung tissue, in ways that make them vulnerable to specific cancer-causing gene ...

Researchers report that the tumor-suppressive protein TJP2 stabilizes TIMM21, which boosts SPRY4 and dampens ERK1/2 signaling to restrain clear cell renal cell carcinoma progression.

Laboratory tests show that extracts of Thailand's flavonoid-rich Yoom Noon rice kill colorectal cancer cells, block their ...

Cancer cells are known to reawaken embryonic genes to grow. A new study reveals the disease also hijacks the proteins, or "editors," that control how those genes are read. The findings, published in ...

Patient-derived, lab-grown cell cultures called organoids have revolutionized cancer research. And a new lab for growing those cell cultures for early drug testing is under development ...

Changes in metabolic activity in tumor cells is one of the hallmarks of cancer. Cancer cells exhibit the Warburg effect with high glucose consumption for their energy needs. This ...

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment. However, cancer cells have developed immune evasion strategies, leading to poor ...